# News – Aclarion
Canonical URL: https://biopharmsignal.com/news/ACON/news-aclarion-934d0e75
Ticker: ACON
Company: Aclarion
Source: Aclarion
Published: 2026-07-07 13:28 EST
Original Source URL: https://investors.aclarion.com/news
## Summary

CAREERSPATENTSPAYMENTSPHYSICIAN PORTALCAUTION (United States): Federal law restricts this device to sale by or on the order of a physician. Note: Statement applicable to NOCICALC-LS only in the US. The NOCISCAN...

## Article Body
CAREERS

PATENTS

PAYMENTS

PHYSICIAN PORTAL

CAUTION (United States): Federal law restricts this device to sale by or on the order of a physician. Note: Statement applicable to NOCICALC-LS only in the US. The NOCISCAN suite is comprised of the NOCICALC-LS and NOCIGRAM-LS post processing products.

© 2026 Aclarion | All Rights Reserved | 740-00202-REC-01; 05/2022
## Recent Company News
- 2026-07-09 15:22 EST — [Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal](https://biopharmsignal.com/news/ACON/aclarion-rejects-echo-lake-capital-s-unsolicited-acquisition-proposal-1610a9fa) — Source: Aclarion
- 2026-07-09 15:22 EST — [Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform](https://biopharmsignal.com/news/ACON/aclarion-partners-with-pria-healthcare-to-advance-reimbursement-and-commercial-a-d8824477) — Source: Aclarion
- 2026-07-09 15:22 EST — [Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub](https://biopharmsignal.com/news/ACON/aclarion-to-present-at-the-planet-microcap-las-vegas-powered-by-microcapclub-07382a59) — Source: Aclarion
- 2026-07-08 14:40 EST — [Aclarion Announces Texas Spine Care Center as New CLARITY Site](https://biopharmsignal.com/news/ACON/aclarion-announces-texas-spine-care-center-as-new-clarity-site-af21995b) — Source: Aclarion
- 2026-07-07 13:28 EST — [News – Aclarion](https://biopharmsignal.com/news/ACON/news-aclarion-934d0e75) — Source: Aclarion
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)